Biohaven Pharmaceutical Holding Company Ltd. Accumulated Other Comprehensive Income
Biohaven Pharmaceutical Holding Company Ltd. had Accumulated Other Comprehensive Income of -$5.81 million as of 2022-06-30, per its 10-Q filed 2022-08-05.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2022-08-05
- 2022-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$5.81M.
- 2022-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.40M.
- 2021-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$73.00K.
- 2021-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $82.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2022-06-30 | -$5.81M 10-Q · filed 2022-08-05 |
| 2022-03-31 | -$2.40M 10-Q · filed 2022-05-10 |
| 2021-12-31 | -$73.00K 10-Q · filed 2022-08-05 |
| 2021-09-30 | $82.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $280.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $409.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $314.00K 10-K · filed 2022-02-25 |
| 2020-09-30 | $251.00K 10-Q · filed 2020-11-09 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 |